Send a message to the show! For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the Netherlands pharmacovigilance centre Lareb explain why we shouldn’t abuse this powerful but fragile tool. Tune in to ... Show More
Feb 2026
#44 Rethinking medical device safety, part 2 – Omar Aimer
Send a message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and former co ... Show More
21m 22s
Jan 2026
#43 Rethinking medical device safety, part 1 – Omar Aimer
Send a message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can leave patients vulnerable. In this two-part episode, Omar Aimer, president of ISoP and form ... Show More
22m 44s
Apr 2021
Clinical Implications & Application of Pharmacogenomics | PGX for Pharmacists
Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. ... Show More
24m 6s
May 2022
Patient-Reported Outcomes in Clinical Trials
<p>JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ... Show More
14m 26s